THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
In the article the authors consider some concerns of clinical efficacy and safety of rosuvastatin - the most powerful representative of the group of statins. The review contains the results of clinical trials, demonstrating its high lipid-lowering efficacy, impact on surrogate and primary endpoints...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2013-06-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/5550 |